Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 101

Sort by

Sort Order Select

Journal Articles

Clinical Characteristics and Prognosis of Subcutaneous Panniculitis-like T-Cell Lymphoma Based on the SEER Database

Lijuan Zhang, Qiaochu Lin, Lin Qi, Jie Ji, Ting Niu, Bing Xiang

Blood (2024) 144 (Supplement 1): 6411.

https://doi.org/10.1182/blood-2024-207332

Published: 2024

Journal Articles

Analysis of Fungal Infections in CLL Patients with BTK Inhibitors from 12 Randomized Clinical Trials

Yutong Wang, Ting Niu

Blood (2024) 144 (Supplement 1): 6795.

https://doi.org/10.1182/blood-2024-204258

Published: 2024

Journal Articles

Global, Regional, and National Burden of Hodgkin Lymphoma from 1990 to 2021: Estimates from the 2021 Global Burden of Disease Study

Mengyao Wang, Qian Hu, He LI, Yi Liao, Ting Niu

Blood (2024) 144 (Supplement 1): 6370.

https://doi.org/10.1182/blood-2024-208562

Published: 2024

Journal Articles

Mini-Dosed Blinatumomab Maintenance Therapy Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute B-Cell Lymphoblastic Leukemia

Jie Ji, Zhigang Liu, Xinchuan Chen, Pu Kuang, Tian Dong, Hang Zhang, Ting Niu, Sr., Ting Liu

Blood (2024) 144 (Supplement 1): 1049.

https://doi.org/10.1182/blood-2024-210268

Published: 2024

Journal Articles

Lower Respiratory Tract Pathogen Colonization Detected By Metagenomic Next-Generation Sequencing of Bronchoalveolar Lavage Fluid before Allogeneic Hematopoietic Stem Cell Transplantation and Its Predicting Value for Post-Transplant Infection

Hang Zhang, Hui Liu, Ting Liu, Ting Niu, Zhigang Liu, Jie Ji

Blood (2024) 144 (Supplement 1): 3512.

https://doi.org/10.1182/blood-2024-209691

Published: 2024

Journal Articles

Orelabrutinib-Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Treatment of Marginal Zone Lymphoma: A Retrospective Study

He LI, Jiazhuo Liu, Yuhui Chen, Pazilaiti Tuohuti, Yutong Wang, Xinzhu Tang, Bing Xiang, Yongqian Jia, Yu Wu, Yun Tang, Yong Guo, Jie Wang, Yuhuan Zheng, Yu Liu, Ting Niu

Blood (2024) 144 (Supplement 1): 6308.

https://doi.org/10.1182/blood-2024-206464

Published: 2024

Journal Articles

Pharmacological and Mechanism Study of a New RIPK1 Inhibitor Via Necroptosis to Treat Hemophagocytic Lymphohistiocytosis

Jinbing Zhu, Jinjin Wang, Ailin Zhao, Ting Niu

Blood (2024) 144 (Supplement 1): 810.

https://doi.org/10.1182/blood-2024-206843

Published: 2024

Journal Articles

First-in-Human Phase I/IIa Safety and Efficacy of Flonoltinib Maleate, a New Generation of JAK2/FLT3 Inhibitor in Myelofibrosis

Lijuan Chen, Yongsheng Wang, Jie Wang, Linyu Yang, Ting Niu

Blood (2024) 144 (Supplement 1): 486.

https://doi.org/10.1182/blood-2024-210674

Published: 2024

Journal Articles

Real-World Clinical Outcomes of Daratumumab-Based Regimens in Chinese Patients with Multiple Myeloma By Cytogenetic Risk: A Subgroup Analysis of the MMY4032 Study

Luqun Wang, Wei Yang, Ting Niu, Yafei Wang, Rong Fu, Yuping Zhong, Kaiyang Ding, Kai Sun, Baijun Fang, Hong Liu, Wenbin Qian, Hui Liu, Yanhui Li, Yishen Yang, Jianmin Zhuo, Xi Chen, Canchan Cui, Jin Lu

Blood (2024) 144 (Supplement 1): 7874.

https://doi.org/10.1182/blood-2024-201134

Published: 2024

Journal Articles

Fc Receptor-like 5 (FCRL5)-Directed CAR-T Cells Exhibit Antitumor Activity Against Multiple Myeloma

Zhengyu Yu, Aipin Tong, Ting Niu

Blood (2024) 144 (Supplement 1): 7091.

https://doi.org/10.1182/blood-2024-207347

Published: 2024

Journal Articles

Mecapegfilgrastim for Preventing Chemotherapy-Induced Neutropenia in Patients with Diffuse Large B-Cell Lymphoma: A Multicenter, Open-Label, Randomized Controlled Trial

Jie Wang, He LI, Qiaochu Lin, Kun Yang, Chunrong Ma, Hong Zhai, Jin Wei, Yan Zuo, Jie Zhou, Ting Niu

Blood (2024) 144 (Supplement 1): 6498.

https://doi.org/10.1182/blood-2024-206431

Published: 2024

Journal Articles

Single-Center Retrospective Clinical Evaluation of 7-Day Venetoclax Combined with Decitabine and CAG Regimen for AML Older Than 60 Years

Yong Guo, Yiwen Du, Hongbing Ma, Yuping Gong, Ting Niu

Blood (2024) 144 (Supplement 1): 6006.

https://doi.org/10.1182/blood-2024-207662

Published: 2024

Journal Articles

Ixazomib Based Regimens As Front-Line Treatment in Newly Diagnosed Multiple Myeloma Patients in China: A Real-World Data from Infinite Study

Fu Cheng Cheng, Song Jin, Junling Zhuang, Xin Zhou, Fan Zhou, Yuhua Li, Kaiyang Ding, Ting Niu, Wenming Chen, Baijun Fang, Li-Li Chen, Rong Fu, Hao Zhang, Jiaping Fu, Xiuju Wang, Sha Liu, Lin Li, Depei Wu

Blood (2024) 144 (Supplement 1): 6970.

https://doi.org/10.1182/blood-2024-204366

Published: 2024

Journal Articles

Effectiveness of Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria in China: A Real World Study

He LI, Xinmei Yu, Juan Qiu, Lei Jia, Huanling Zhu, Ting Niu, Zhigang Liu, Chuan He

Blood (2024) 144 (Supplement 1): 5696.

https://doi.org/10.1182/blood-2024-212316

Published: 2024

Journal Articles

Targeting YTHDC1 Inhibited the Progression of Mantle Cell Lymphoma By Inhibiting the Expression of MYC Gene through m6A Modification

Hui Zhou, Li Wang, Ruicheng Yang, Guifeng Lin, Hailin Zhang, Ting Niu

Blood (2024) 144 (Supplement 1): 5821.

https://doi.org/10.1182/blood-2024-207319

Published: 2024

Journal Articles

A Novel Conditioning Regimen Combining Selinexor with Melphalan Could Improve Survival of Patients with Multiple Myeloma

Liangliang Ma, Jingping Zhang, Xiaoqing Chen, Shanglun Yang, Youmei Fei, QIan Hu, Jian Li, Caigang Xu, Ting Niu, Yongqian Jia

Blood (2024) 144 (Supplement 1): 7066.

https://doi.org/10.1182/blood-2024-206877

Published: 2024

Journal Articles

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: An Updated Report on the Pivotal Study of Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-Cell ALL) in China

Blood (2024) 144 (Supplement 1): 4196.

https://doi.org/10.1182/blood-2024-199983

Published: 2024

Journal Articles

Harnessing Ferroptosis and Photothermal Effects: A New Paradigm in Aggressive Lymphoma Therapy

Mengyao Wang, Qian Hu, Ting Niu

Blood (2024) 144 (Supplement 1): 2208.

https://doi.org/10.1182/blood-2024-208012

Published: 2024

Journal Articles

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Blood (2024) 144 (Supplement 1): 2187.

https://doi.org/10.1182/blood-2024-206919

Published: 2024

Journal Articles

Efficacy and Safety of Axicabtagene Ciloleucel (Axi-cel) for the Treatment of Relapse/Refractory Non-Hodgkin's Lymphoma: Real-World Data in Chinese Population

Blood (2024) 144 (Supplement 1): 5115.

https://doi.org/10.1182/blood-2024-207186

Published: 2024

NARROW

Clinical Characteristics and Prognosis of Subcutaneous Panniculitis-like T-Cell Lymphoma Based on the SEER Database

Analysis of Fungal Infections in CLL Patients with BTK Inhibitors from 12 Randomized Clinical Trials

Global, Regional, and National Burden of Hodgkin Lymphoma from 1990 to 2021: Estimates from the 2021 Global Burden of Disease Study

Mini-Dosed Blinatumomab Maintenance Therapy Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute B-Cell Lymphoblastic Leukemia

Lower Respiratory Tract Pathogen Colonization Detected By Metagenomic Next-Generation Sequencing of Bronchoalveolar Lavage Fluid before Allogeneic Hematopoietic Stem Cell Transplantation and Its Predicting Value for Post-Transplant Infection

Orelabrutinib-Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Treatment of Marginal Zone Lymphoma: A Retrospective Study

Pharmacological and Mechanism Study of a New RIPK1 Inhibitor Via Necroptosis to Treat Hemophagocytic Lymphohistiocytosis

First-in-Human Phase I/IIa Safety and Efficacy of Flonoltinib Maleate, a New Generation of JAK2/FLT3 Inhibitor in Myelofibrosis

Real-World Clinical Outcomes of Daratumumab-Based Regimens in Chinese Patients with Multiple Myeloma By Cytogenetic Risk: A Subgroup Analysis of the MMY4032 Study

Fc Receptor-like 5 (FCRL5)-Directed CAR-T Cells Exhibit Antitumor Activity Against Multiple Myeloma

Mecapegfilgrastim for Preventing Chemotherapy-Induced Neutropenia in Patients with Diffuse Large B-Cell Lymphoma: A Multicenter, Open-Label, Randomized Controlled Trial

Single-Center Retrospective Clinical Evaluation of 7-Day Venetoclax Combined with Decitabine and CAG Regimen for AML Older Than 60 Years

Ixazomib Based Regimens As Front-Line Treatment in Newly Diagnosed Multiple Myeloma Patients in China: A Real-World Data from Infinite Study

Effectiveness of Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria in China: A Real World Study

Targeting YTHDC1 Inhibited the Progression of Mantle Cell Lymphoma By Inhibiting the Expression of MYC Gene through m6A Modification

A Novel Conditioning Regimen Combining Selinexor with Melphalan Could Improve Survival of Patients with Multiple Myeloma

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: An Updated Report on the Pivotal Study of Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-Cell ALL) in China

Harnessing Ferroptosis and Photothermal Effects: A New Paradigm in Aggressive Lymphoma Therapy

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Efficacy and Safety of Axicabtagene Ciloleucel (Axi-cel) for the Treatment of Relapse/Refractory Non-Hodgkin's Lymphoma: Real-World Data in Chinese Population

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only